Other Neurological Indications

In addition to ischemic stroke, Athersys has established collaborative relationships with independent investigators that are evaluating the potential application for MultiStem to treat a range of other neurological indications, including traumatic brain injury (TBI), neonatal hypoxic ischemia, spinal cord injury, multiple sclerosis (MS), and Parkinson’s disease. Each of these represent significant areas of unmet medical need, where conventional approaches have had limited impact, and also represent substantial market opportunities.